Current peptide and protein candidates challenging HIV therapy beyond the vaccine Era

• Main Authors: Koollawat Chupradit, Sutpirat Moonmuang, Sawitree Nangola, Kuntida Kitidee, Umpa Yasamut, Marylène Mougel, Chatchai Tayapiwatana
• Format: Journal
• Published: 2018
• Subjects: Immunology and Microbiology; Agricultural and Biological Sciences
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85030563444&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/43618
• Institution: Chiang Mai University

© 2017 by the authors.Licensee MDPI, Basel, Switzerland. Human immunodeficiency virus (HIV) is a causative agent of acquired immune deficiency syndrome (AIDS). Highly active antiretroviral therapy (HAART) can slow down the replication of HIV-1, leading to an improvement in the survival of HIV-1-infe...